A. Barrero

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

A. Borobia, B. Clotet, J. Prado, 2022, The Lancet Regional Health - Europe.

Impact of COVID‐19 Infection on Patients with Cancer: Experience in a Latin American Country: The ACHOCC‐19 Study

P. Pinilla, J. Segovia, F. Contreras, 2021, The oncologist.